Company intelligence / Profile preview

Lotte Holdings

Seoul, Seoul, South Korea

Ownership: Private
Employees: ~128
Development stage: Other

Overview

Lotte Holdings, via Lotte Biologics, operates major biologics and ADC manufacturing sites in South Korea and the U.S., with CDMO capabilities from preclinical to commercial, and has recently secured late-stage to commercial manufacturing partnerships with global pharma clients

Modalities: Monoclonal antibodyAntibody-drug conjugate (ADC)BiologicSmall molecule
Industry: Contract Manufacturing Organization

Partnerships

Multiple late-stage and commercial manufacturing contracts with global U.S. biopharmaceutical companies (details confidential)

Beyond the preview

Go deeper on Lotte Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lotte Holdings.

Explore the full profile